RegeneRx Biopharmaceuticals, Inc.
RGRX
$0.00
-$0.16-99.88%
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 101.60K | 290.90K | 478.40K | 706.60K | 925.30K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.70K | 10.00K | 21.00K | 19.00K | 13.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 6.00K | -- | -- | -- |
| Total Current Assets | 123.30K | 306.90K | 499.40K | 725.60K | 938.60K |
|
|
|||||
| Total Current Assets | 123.30K | 306.90K | 499.40K | 725.60K | 938.60K |
| Net Property, Plant & Equipment | 57.80K | 69.50K | 75.80K | 4.20K | 16.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.80K | 5.80K | 5.80K | 5.80K | 5.80K |
| Total Assets | 186.80K | 382.20K | 581.00K | 735.50K | 960.50K |
|
|
|||||
| Total Accounts Payable | 38.70K | 63.80K | 37.20K | 45.40K | 31.70K |
| Total Accrued Expenses | 469.30K | 369.70K | 329.10K | 306.50K | 278.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.21M | 43.40K | 33.20K | 4.20K | 16.30K |
| Total Finance Division Other Current Liabilities | 76.80K | 76.80K | 76.80K | 76.80K | 76.80K |
| Total Other Current Liabilities | 76.80K | 76.80K | 76.80K | 76.80K | 76.80K |
| Total Current Liabilities | 1.80M | 553.70K | 476.20K | 432.90K | 403.00K |
|
|
|||||
| Total Current Liabilities | 1.80M | 553.70K | 476.20K | 432.90K | 403.00K |
| Long-Term Debt | 262.00K | 1.37M | 1.31M | 1.25M | 1.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.70K | 30.20K | 42.10K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.85M | 1.87M | 1.89M | 1.91M | 1.93M |
| Total Liabilities | 3.93M | 3.83M | 3.72M | 3.60M | 3.53M |
|
|
|||||
| Common Stock & APIC | 108.86M | 108.77M | 108.69M | 108.60M | 108.35M |
| Retained Earnings | -112.60M | -112.22M | -111.83M | -111.46M | -110.91M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.74M | -3.45M | -3.14M | -2.86M | -2.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.74M | -3.45M | -3.14M | -2.86M | -2.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.74M | -3.45M | -3.14M | -2.86M | -2.57M |
|
|
|||||